High prevalence of type 2 diabetes and pre-diabetes in adult Zoroastrians in Yazd, Iran: a cross-sectional study.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4455301)

Published in Electron Physician on March 01, 2015

Authors

Saeedhossein Khalilzadeh1, Mohammad Afkhami-Ardekani2, Mohammadhosain Afrand3

Author Affiliations

1: Assistant Professor, Department of Endocrinology, Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
2: Professor, Department of Endocrinology, Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
3: M.D, Medical Scientific Association, Ali-Ebne Abitaleb Faculty of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran.

Articles cited by this

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care (1998) 18.69

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14

Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev (2000) 7.81

Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med (2002) 6.32

High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia (2001) 5.79

Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med (2006) 5.61

Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. BMJ (1998) 4.90

Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med (1996) 4.58

The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care (2002) 4.52

Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care (2007) 3.57

Genetic and environmental influences on serum lipid levels in twins. N Engl J Med (1993) 3.43

An accelerated nutrition transition in Iran. Public Health Nutr (2002) 3.39

Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia (2006) 3.35

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract (2003) 3.06

Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care (2006) 3.06

Increasing prevalence of diabetes mellitus in Oman. Diabet Med (2002) 2.98

Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care (2003) 2.96

Screening for diabetes in general practice: cross sectional population study. BMJ (2001) 2.64

Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health (2009) 1.68

Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care (1995) 1.67

Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract (2007) 1.57

Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab (2005) 1.39

Epidemiology of diabetes among Arab Americans. Diabetes Care (2003) 1.30

Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study. Exp Clin Endocrinol Diabetes (2006) 1.24

General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res (2005) 1.19

Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition study. Diabetes Care (2001) 1.16

Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev (2000) 1.07

Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J (1991) 1.07

High prevalence of diabetes in Adana, a southern province of Turkey. Diabetes Care (2003) 1.04

Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol (2001) 0.97

Impaired fasting glucose and impaired glucose tolerance in urban population in India. Diabet Med (2003) 0.96

Discordant patterns of mtDNA and ethno-linguistic variation in 14 Iranian Ethnic groups. Hum Hered (2011) 0.94

Cross-sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women. J Atheroscler Thromb (2010) 0.92

Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis (2002) 0.86

The prevalence of diabetes and impaired glucose tolerance in Sivas, Central Anatolia, Turkey. Diabetes Care (2005) 0.85